265 related articles for article (PubMed ID: 30307671)
41. Dentate Nucleus Signal Intensity Decrease on T1-weighted MR Images after Switching from Gadopentetate Dimeglumine to Gadobutrol.
Behzadi AH; Farooq Z; Zhao Y; Shih G; Prince MR
Radiology; 2018 Jun; 287(3):816-823. PubMed ID: 29533723
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of Gadolinium Retention After Serial Administrations of a Macrocyclic Gadolinium-Based Contrast Agent (Gadobutrol): A Single-Institution Experience With 189 Patients.
Yoo RE; Sohn CH; Kang KM; Yun TJ; Choi SH; Kim JH; Park SW
Invest Radiol; 2018 Jan; 53(1):20-25. PubMed ID: 28742734
[TBL] [Abstract][Full Text] [Related]
43. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients.
Kahn J; Posch H; Steffen IG; Geisel D; Bauknecht C; Liebig T; Denecke T
Radiology; 2017 Mar; 282(3):708-716. PubMed ID: 28076722
[TBL] [Abstract][Full Text] [Related]
44. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
Ozturk K; Nascene D
AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
[TBL] [Abstract][Full Text] [Related]
45. Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
Cao Y; Zhang Y; Shih G; Zhang Y; Bohmart A; Hecht EM; Prince MR
Invest Radiol; 2016 Nov; 51(11):677-682. PubMed ID: 27272543
[TBL] [Abstract][Full Text] [Related]
46. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
[TBL] [Abstract][Full Text] [Related]
47. Pediatric Brain: No Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-weighted MR Images after Consecutive Exposure to a Macrocyclic Gadolinium-based Contrast Agent.
Radbruch A; Haase R; Kickingereder P; Bäumer P; Bickelhaupt S; Paech D; Wick W; Schlemmer HP; Seitz A; Bendszus M
Radiology; 2017 Jun; 283(3):828-836. PubMed ID: 28273007
[TBL] [Abstract][Full Text] [Related]
48. Intrathecal Contrast-Enhanced Magnetic Resonance Imaging-Related Brain Signal Changes: Residual Gadolinium Deposition?
Öner AY; Barutcu B; Aykol Ş; Tali ET
Invest Radiol; 2017 Apr; 52(4):195-197. PubMed ID: 27755154
[TBL] [Abstract][Full Text] [Related]
49. Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.
Koiso T; Yamamoto M; Watanabe S; Barfod BE
Neuroradiol J; 2019 Jun; 32(3):215-224. PubMed ID: 30924388
[TBL] [Abstract][Full Text] [Related]
50. In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.
Tedeschi E; Palma G; Canna A; Cocozza S; Russo C; Borrelli P; Lanzillo R; Angelini V; Postiglione E; Morra VB; Salvatore M; Brunetti A; Quarantelli M
Eur Radiol; 2016 Dec; 26(12):4577-4584. PubMed ID: 26905870
[TBL] [Abstract][Full Text] [Related]
51. High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2015 Dec; 50(12):805-10. PubMed ID: 26523910
[TBL] [Abstract][Full Text] [Related]
52. Do Gadolinium-Based Contrast Agents Affect
Bauer K; Lathrum A; Raslan O; Kelly PV; Zhou Y; Hewing D; Botkin C; Turner JA; Osman M
J Nucl Med Technol; 2017 Mar; 45(1):30-33. PubMed ID: 27834725
[TBL] [Abstract][Full Text] [Related]
53. Gadolinium deposition in the brain is related to various contrast agents: a matched case-control study.
Bi Q; Li H; Du J; Li H; Li Q; Wang J; Huang Y; Gong X
Clin Radiol; 2022 Apr; 77(4):299-306. PubMed ID: 35094817
[TBL] [Abstract][Full Text] [Related]
54. Effect of Exposure to Gadodiamide and Brain Irradiation on T
Mallio CA; Parillo M; Zobel BB; Parizel PM; Quattrocchi CC
J Magn Reson Imaging; 2020 Nov; 52(5):1525-1530. PubMed ID: 32478956
[TBL] [Abstract][Full Text] [Related]
55. A retrospective cohort evaluation of the effect of multiple administrations of gadopentetate dimeglumine on brain magnetic resonance imaging T1-weighted signal.
Towbin AJ; Zhang B; Dillman JR
Pediatr Radiol; 2021 Mar; 51(3):457-470. PubMed ID: 33399985
[TBL] [Abstract][Full Text] [Related]
56. Measurements of signal intensity of globus pallidus and dentate nucleus suggest different deposition characteristics of macrocyclic GBCAs in children.
Olchowy C; Maciąg EJ; Sanchez-Montanez A; Olchowy A; Delgado I; Vazquez E
PLoS One; 2018; 13(12):e0208589. PubMed ID: 30586415
[TBL] [Abstract][Full Text] [Related]
57. Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study.
Bjørnerud A; Vatnehol SAS; Larsson C; Due-Tønnessen P; Hol PK; Groote IR
Radiology; 2017 Nov; 285(2):434-444. PubMed ID: 28885891
[TBL] [Abstract][Full Text] [Related]
58. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
59. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
[TBL] [Abstract][Full Text] [Related]
60. Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
Zivadinov R; Bergsland N; Hagemeier J; Ramasamy DP; Dwyer MG; Schweser F; Kolb C; Weinstock-Guttman B; Hojnacki D
Neurology; 2019 Aug; 93(6):e611-e623. PubMed ID: 31285398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
